Australia markets close in 5 hours 51 minutes
  • ALL ORDS

    6,396.80
    -38.80 (-0.60%)
     
  • ASX 200

    6,184.60
    -44.80 (-0.72%)
     
  • AUD/USD

    0.7057
    +0.0005 (+0.08%)
     
  • OIL

    41.51
    +0.05 (+0.12%)
     
  • GOLD

    1,914.20
    -1.20 (-0.06%)
     
  • BTC-AUD

    16,928.62
    +1,253.77 (+8.00%)
     
  • CMC Crypto 200

    239.54
    +0.62 (+0.26%)
     
  • AUD/EUR

    0.5963
    +0.0004 (+0.06%)
     
  • AUD/NZD

    1.0717
    +0.0005 (+0.05%)
     
  • NZX 50

    12,489.56
    +27.51 (+0.22%)
     
  • NASDAQ

    11,677.84
    +43.49 (+0.37%)
     
  • FTSE

    5,889.22
    +4.57 (+0.08%)
     
  • Dow Jones

    28,308.79
    +113.37 (+0.40%)
     
  • DAX

    12,736.95
    -117.71 (-0.92%)
     
  • Hang Seng

    24,569.54
    +27.28 (+0.11%)
     
  • NIKKEI 225

    23,567.04
    -104.09 (-0.44%)
     

Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Simply Wall St
·5-min read

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.

Given this risk, we thought we'd take a look at whether Atomo Diagnostics (ASX:AT1) shareholders should be worried about its cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

See our latest analysis for Atomo Diagnostics

How Long Is Atomo Diagnostics' Cash Runway?

You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. In June 2020, Atomo Diagnostics had AU$27m in cash, and was debt-free. Importantly, its cash burn was AU$8.3m over the trailing twelve months. Therefore, from June 2020 it had 3.3 years of cash runway. Notably, however, the one analyst we see covering the stock thinks that Atomo Diagnostics will break even (at a free cash flow level) before then. If that happens, then the length of its cash runway, today, would become a moot point. Depicted below, you can see how its cash holdings have changed over time.

debt-equity-history-analysis
debt-equity-history-analysis

How Is Atomo Diagnostics' Cash Burn Changing Over Time?

In our view, Atomo Diagnostics doesn't yet produce significant amounts of operating revenue, since it reported just AU$5.4m in the last twelve months. As a result, we think it's a bit early to focus on the revenue growth, so we'll limit ourselves to looking at how the cash burn is changing over time. Remarkably, it actually increased its cash burn by 211% in the last year. With that kind of spending growth its cash runway will shorten quickly, as it simultaneously uses its cash while increasing the burn rate. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years.

How Hard Would It Be For Atomo Diagnostics To Raise More Cash For Growth?

While Atomo Diagnostics does have a solid cash runway, its cash burn trajectory may have some shareholders thinking ahead to when the company may need to raise more cash. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. Many companies end up issuing new shares to fund future growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.

Since it has a market capitalisation of AU$202m, Atomo Diagnostics' AU$8.3m in cash burn equates to about 4.1% of its market value. Given that is a rather small percentage, it would probably be really easy for the company to fund another year's growth by issuing some new shares to investors, or even by taking out a loan.

Is Atomo Diagnostics' Cash Burn A Worry?

As you can probably tell by now, we're not too worried about Atomo Diagnostics' cash burn. For example, we think its cash runway suggests that the company is on a good path. While we must concede that its increasing cash burn is a bit worrying, the other factors mentioned in this article provide great comfort when it comes to the cash burn. There's no doubt that shareholders can take a lot of heart from the fact that at least one analyst is forecasting it will reach breakeven before too long. After considering a range of factors in this article, we're pretty relaxed about its cash burn, since the company seems to be in a good position to continue to fund its growth. Its important for readers to be cognizant of the risks that can affect the company's operations, and we've picked out 1 warning sign for Atomo Diagnostics that investors should know when investing in the stock.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts)

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.